Figure S1 from Prognostic Value of Residual Disease after Neoadjuvant Therapy in HER2-Positive Breast Cancer Evaluated by Residual Cancer Burden, Neoadjuvant Response Index, and Neo-Bioscore

• DOI: 10.1158/1078-0432.22473777.v1
• Publication Date: 2023-04-01T14:28:59Z
• Authors: Tessa G. Steenbru...; Maartje van Seijen; Liselore M. Janssen; Mette S. van Rams...; Erik van Werkhoven; Marie-Jeanne T.D....; Jelle Wesseling; Esther H. Lips; Gabe S. Sonke
• Keywords: Neoadjuvant Therapy

Figure S1 from Prognostic Value of Residual Disease after Neoadjuvant Therapy in HER2-Positive Breast Cancer Evaluated by Burden, Response Index, and Neo-Bioscore